FDA NDC Directory · JSON-LD · Markdown

Denosumab-BMWO

NDC 72606-059 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namedenosumab-bmwo
Labeler / ManufacturerCELLTRION USA, Inc.
Marketing categoryBiologic License Application · App BLA761404
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsDENOSUMAB (120 mg/1.7mL)
Marketing started20250910
Package count1

External sources

Source: openFDA. Public-domain (CC0).